89 related articles for article (PubMed ID: 212355)
21. Further studies on an immunoenzymatic assay for herpes simplex virus tumor-associated antigen.
Tarro G; Flaminio G; Maturo S; Esposito C; Cocchiara R
Clin Immunol Immunopathol; 1982 Oct; 25(1):126-32. PubMed ID: 6295672
[No Abstract] [Full Text] [Related]
22. [Neutralizing antibodies to herpesvirus type 2 in the blood of women with genital cancer].
Andonov P; Dundarov S; Iurkov K; Karag'ozov I
Vopr Onkol; 1972; 18(4):54-8. PubMed ID: 4337597
[No Abstract] [Full Text] [Related]
23. Summary of informal discussion of part II of genital herpesvirus.
Nahmias AJ
Cancer Res; 1973 Jun; 33(6):1483-4. PubMed ID: 4124114
[No Abstract] [Full Text] [Related]
24. Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients.
Heise ER; Kucera LS; Raben M; Homesley H
Cancer Res; 1979 Oct; 39(10):4022-6. PubMed ID: 225014
[No Abstract] [Full Text] [Related]
25. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
26. [Correlation of human papilloma virus (HPV) and herpes simplex virus-2 (HSV-2)in the viral etiology of carcinoma of uterine cervix].
Meng XJ
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):108-10. PubMed ID: 2553361
[TBL] [Abstract][Full Text] [Related]
27. An immuno-enzymatic assay for herpes simplex virus tumour associated antigen in gynecological oncology.
Magli G; Scimone C; Flaminio G; D'Alessandro G; Mascolo A; Magli R; Saladino I
Eur J Gynaecol Oncol; 1982; 3(2):101-6. PubMed ID: 6299742
[TBL] [Abstract][Full Text] [Related]
28. Uterine tumors.
Kato H
Immunol Ser; 1990; 53():385-95. PubMed ID: 2100568
[No Abstract] [Full Text] [Related]
29. [Correlation of HSV-2-induced early antigen with antibodies from cervical carcinoma patients].
Jiang JW
Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):107-9, 126. PubMed ID: 3017644
[No Abstract] [Full Text] [Related]
30. Herpesvirus hominis: from latency to carcinogenesis?
Aurelian L
Johns Hopkins Med J Suppl; 1973; 2():245-66. PubMed ID: 4137697
[No Abstract] [Full Text] [Related]
31. An evaluation of humoral antibody responses in patients with carcinoma of the cervix.
Vos GH; Hammond MG; Vos D; Grobbelaar BG; Auslander HP; Marescotti G
J Obstet Gynaecol Br Commonw; 1972 Nov; 79(11):1040-6. PubMed ID: 4642378
[No Abstract] [Full Text] [Related]
32. Types of cell-mediated immune response in invasive zone of carcinoma of the uterine cervix.
Kozłowski H; Hrabowska M
Arch Geschwulstforsch; 1979; 49(3):240-50. PubMed ID: 496564
[No Abstract] [Full Text] [Related]
33. Studies of tumor-specific and herpesvirus nonvirion antigens.
Hollinshead A; Tarro G; Foster WA; Seigel LJ; Jaffurs W
Cancer Res; 1974 May; 34(5):1122-5. PubMed ID: 4842911
[No Abstract] [Full Text] [Related]
34. [Lymph node metastasis in microcarcinoma of the uterine cervix].
Rohde E; Tessmann D
Zentralbl Gynakol; 1993; 115(3):133-5. PubMed ID: 8465626
[No Abstract] [Full Text] [Related]
35. Cervical carcinoma antigens in the diagnosis of human squamous cell carcinoma of the cervix.
Haines HG; McCoy JP; Hofheinz DE; Ng AB; Nordqvist SR; Leif RC
J Natl Cancer Inst; 1981 Mar; 66(3):465-74. PubMed ID: 7009947
[TBL] [Abstract][Full Text] [Related]
36. Comparative diagnostic aspects of herpes simplex virus tumor-associated antigens.
Notter MF; Docherty JJ
J Natl Cancer Inst; 1976 Sep; 57(3):483-8. PubMed ID: 185398
[TBL] [Abstract][Full Text] [Related]
37. [Clinico-immunologic changes in patients with cervical cancer after treatment with thymalin].
Dekster LI; Nikolaeva LIa; Bokhman IaV; Letskiĭ VB; Morozov VG
Vopr Onkol; 1984; 30(3):29-32. PubMed ID: 6608824
[TBL] [Abstract][Full Text] [Related]
38. Stages of development of immunologic response in the regional lymph nodes in invasive cancer of the uterine cervix.
Kozlowski H; Hrabowska M
Arch Geschwulstforsch; 1977; 47(6):550-60. PubMed ID: 607906
[TBL] [Abstract][Full Text] [Related]
39. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
Göcze P; Vahrson H
Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
